Concepedia

Stuart Hawtin

SH

Statistics

Publications

30

Citations

1.3K

H-Index

22

Active since

1995

Affiliations

University of Birmingham(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Genomics Institute of the Novartis Research Foundation

MSD (UK) Limited (United Kingdom)

Stuart Hawtin is an author at University of Birmingham specializing in pharmacology, life sciences, and cell signaling.

ORCID

Publications per year

1995–2023

30

Publications

30

The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides

Mark S. Shearman, Stuart Hawtin, Vipula J. Tailor · Journal of Neurochemistry · 1995 · 204 citations

, , +17

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells

Scott J. Pollack, Isobel I. J. Sadler, Stuart Hawtin et al. · Neuroscience Letters · 1995 · 100 citations

, , +14

Systematic Analysis of the Entire Second Extracellular Loop of the V1a Vasopressin Receptor

Matthew T. Conner, Stuart Hawtin, John Simms et al. · Journal of Biological Chemistry · 2007 · 83 citations · Full text

, , +2

Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion

Scott J. Pollack, Isobel I. J. Sadler, Stuart Hawtin et al. · Neuroscience Letters · 1995 · 82 citations

, , +16

Palmitoylation of the Vasopressin V1a Receptor Reveals Different Conformational Requirements for Signaling, Agonist-induced Receptor Phosphorylation, and Sequestration

Stuart Hawtin, Andrew B. Tobin, Smita S. Patel et al. · Journal of Biological Chemistry · 2001 · 74 citations · Full text

, , +17

1–5 of 30